Next Quarterly Earnings
Wednesday, August 5, 2026
CW 32
Pre-Market
In 31 days
NeoGenomics
NeoGenomics is a leading US-based oncology diagnostics company. It offers comprehensive molecular, genomic, and pathology cancer testing to physicians, hospitals, and pharmaceutical companies worldwide, advancing precision medicine. The company's innovative diagnostic solutions support targeted cancer treatment and pharmaceutical research.
All Dates
Earnings history data not available
Company Information
Name
NeoGenomics
Country
🇺🇸
More Financial Information